tiprankstipranks
Trending News
More News >
Outlook Therapeutics (OTLK)
NASDAQ:OTLK
US Market

Outlook Therapeutics (OTLK) Income Statement

Compare
1,582 Followers

Outlook Therapeutics Income Statement

Last quarter (Q3 2025), Outlook Therapeutics's total revenue was $1.51M, an increase of Infinity% from the same quarter last year. In Q3, Outlook Therapeutics's net income was $-20.15M. See Outlook Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.41T$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 57.20B$ -113.86K$ -44.19K$ -204.69K$ -262.14K
Operating Expenses
$ 67.12T$ 71.70M$ 53.13M$ 62.87M$ 51.73M
Depreciation and Amortization
$ 0.00$ 113.86K$ 44.19K$ 204.69K$ 262.14K
EBITDA
$ -67.06T$ -72.09M$ -57.38M$ -64.36M$ -51.51M
Operating Income
$ -67.06T$ -71.70M$ -53.13M$ -63.07M$ -51.73M
Other Income/Expenses
$ 3.08T$ -3.66M$ -5.85M$ -2.98M$ -1.43M
Pretax Income
$ -63.98T$ -75.36M$ -58.98M$ -66.05M$ -53.16M
Net Income
$ -62.42T$ -75.37M$ -58.98M$ -66.05M$ -53.16M
Per Share Metrics
Basic EPS
$ -1.79$ -4.06$ -4.72$ -6.23$ -6.96
Diluted EPS
$ -1.79$ -4.06$ -4.72$ -6.23$ -6.96
Weighted Average Shares Outstanding
34.80M 18.55M 12.51M 10.60M 7.63M
Weighted Average Shares Outstanding (Diluted)
25.48M 18.55M 12.51M 10.60M 7.63M
Currency in USD

Outlook Therapeutics Earnings and Revenue History